Replies to post #226431 on Avid Bioservices Inc (CDMO)

[cheynew]

DEPO has 102% institutional ownership and trades at $31.

[Frustrated]

Wow, so it is official the Senior Director of Investor Relations quits Peregrine 18 months into Sunrise. Why in the world would he do that if he knows Peregrine has the goods? This is a huge red flag to go along with Marsten leaving. So we now have a former IHUB poster as our PR lead who allegedly told a shareholder that mgmt was pulling out of a conference for family personal reasons when two weeks later they announced the botched trial. I guess those are qualities mgmt likes and why they may be having a hard time finding the same qualities to fill the BOD. All imo.

PPHM THE COMPANY THAT HAS BEEN LOOKING TO ADD QUALIFIED BOARD MEMBERS SINCE 2010 YET CAN'T FIND A MATCH WITH THE CURRENT CREDENTIALS OF OUR BOD AND THEIR PENNY STOCK PEDIGREE. 75% OF THE BOARD HAS/HAD TIES TO PATRIOTIC SCIENTIFIC WHICH NOW TRADES AT 5 PENNIES YET THE COMPANY CLAIMS TO HAVE AN INDEPENDENT BOD.

PPHM THE COMPANY WHOSE CEO IN MARCH 2014 TALKED ABOUT A PARTNERSHIP COMING TO FRUITION IN UPCOMING YEAR. IT IS NOW July 15 2015, 196 days past the year 2014. CREDIBILITY IS AN ISUUE. ALL IMO.

[revenue_monster]

Ha! Guess he had enough.

[war0001]

Might be looked at as, he's aware of pending buyout and subsequent layoffs.

[biopharm]

Christopher Keenan
Vice President, Investor Relations & Corporate Communications at Depomed, Inc.

Chris Keenan our ex Peregrine employee ? How the web is spun

Depomed was in the portfolio for Tailwind Capital ....along with Archway Marketing, here with the saboteur Jeanette Bleecker (that admitted in her depositions of swapping trial arms that are now sealed to the public but access must be given to new BODs at Peregrine to evaluate IP assets of the corporation.)

Tailwind Capital got mixed up with Investcorp that had to buy Archway Marketing

http://tailwind.com/portfolio


I hope Tailwind Capital is not assessing the value for Peregrine

A. Clayton Perfall
OPERATING EXECUTIVE
Mr. Perfall assists Tailwind in sourcing, evaluating and performing due diligence on business services opportunities. Mr. Perfall serves as the Chairman of the Board of Directors of Diversified and Premier.

Mr. Perfall has over 30 years of experience acquiring and building services companies, including extensive experience executing industry consolidations. He previously served as the CEO of Archway Marketing Services, a North American provider of marketing logistics services which was previously a Tailwind portfolio company. Previously, Mr. Perfall was CFO and director of Snyder Communications (NYSE:SNC).

Mr. Perfall currently serves as director and Chair of the Audit Committees of Colfax Corporation (NYSE:CFX) and Comstock Holding Companies (NASDAQ:CHCI). He served as director and Chair of the Audit Committee of InVentiv Health (NASDAQ:VTIV) from its formation in 1999 until its sale for $1.2 billion in 2010. Mr. Perfall served as the Chair of the Board of Governors of St. Stephen’s & St. Agnes School in Alexandria, VA for five years and is a trustee of the St. Stephen’s & St. Agnes School Foundation.

Mr. Perfall began his career in public accounting with Arthur Andersen in Washington, DC where he earned his CPA designation and was admitted as a partner. He received a B.B.A. from the College of William & Mary where he has served as a trustee for the Mason School of Business.

http://tailwind.com/team/bio/2042

http://www.leveragedloan.com/investcorp-readies-leveraged-loan-backing-archway-marketing-lbo/
_____

http://m.startribune.com/rogers-based-archway-acquired-in-300m-deal/161806745/nnu